Skip to content
Disclosery

Platinum Management (NY) LLC

Follow

13F filer, CIK 1368616, NEW YORK, NY

Platinum Management (NY) LLC reported $22,767,000 across 6 holdings for the quarter ended 2015-06-30, in a 13F-HR/A filed 2015-11-19.

Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0001368616-15-000007

Period
2015-06-30
Reported value
$22.8M
Holdings
6
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PEDEVCO CORPadded+3,375,000$1.52M
NAVIDEA BIOPHARMACEUTICALS Iadded+737,496$1.19M
ECHO THERAPEUTICS INCadded+454,250$772K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VIRCreduced-24,380-$69.6K
DLHCreduced-26,022-$67.5K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2015

Share positions as resolved from 13F-HR/A 0001368616-15-000007, largest first. % of portfolio is the value over $22,767,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NAVIDEA BIOPHARMACEUTICALS INAVIDEA BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: 14,915,631 shares; 2014Q3: 15,046,431 shares; 2014Q4: 14,603,603 shares; 2015Q1: 11,454,831 shares; 2015Q2: 12,192,327 shares 12,192,327$19.6M86.22%+737,496
PEDEVCO CORPPEDEVCO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: 34,444 shares; 2014Q3: not reported; 2014Q4: not reported; 2015Q1: 34,444 shares; 2015Q2: 3,409,444 shares 3,409,444$1.53M6.74%+3,375,000
ECHO THERAPEUTICS INCECHO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: not reported; 2014Q3: not reported; 2014Q4: 2,228,221 shares; 2015Q1: 377,633 shares; 2015Q2: 831,883 shares 831,883$1.41M6.21%+454,250
VIRCVIRCO MFG COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: not reported; 2014Q3: 30,550 shares; 2014Q4: 95,879 shares; 2015Q1: 68,179 shares; 2015Q2: 43,799 shares 43,799$125K0.55%-24,380Timeline
DLHCDLH HLDGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: not reported; 2014Q3: 66,025 shares; 2014Q4: 52,100 shares; 2015Q1: 47,999 shares; 2015Q2: 21,977 shares 21,977$57K0.25%-26,022Timeline
INSPIREMD INCINSPIREMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: not reported; 2014Q3: 24,453 shares; 2014Q4: not reported; 2015Q1: 24,453 shares; 2015Q2: 24,453 shares 24,453$7K0.03%0

How Q2 2015 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001368616-15-000003 superseded2015-08-11acceptance time not in the bulk data set
13F-HR/A 0001368616-15-000004 supersededrestatement2015-08-12acceptance time not in the bulk data set
13F-HR/A 0001368616-15-000007 baserestatement2015-11-19acceptance time not in the bulk data set